This Article Collection highlights research published in 2013-2015 on targeted inhibitor and other cancer therapies.
Novel ALK inhibitors in clinical use and development
Anaplastic lymphoma kinase 1 (ALK-1) is a member of the insulin receptor tyrosine kinase family. ALK-1 was initially found in anaplastic large cell lymphoma (ALCL). ALK mutations have also been implicated in t...
Citation: Journal of Hematology & Oncology 2015 8:17